Skip to content Skip to footer
Mavacamten: Benefits, Reviews, Info, Side Effects!
Rx Details
Mavacamten
MYK-461, CK-274, MYK-224
Mavacamten
Prescription
Medication
Drugs
Prescription Only
reduction in left ventricular outflow tract obstruction, improvement in exercise capacity, alleviation of symptoms associated with hypertrophic cardiomyopathy, potential improvement in quality of life, reduction in cardiac biomarkers associated with heart stress
Atrial Fibrillation, Chest Pain, Dizziness, Dyspnea, Edema, Fatigue, Headache, Heart Failure, Nausea, Palpitations, Syncope
Mavacamten is a medication used primarily for the treatment of obstructive hypertrophic cardiomyopathy. The typical starting dosage for mavacamten is 5 mg taken orally once daily. However, the dosage may be adjusted based on the patient’s response and specific needs, with potential adjustments to 2.5 mg, 10 mg, or 15 mg once daily. It’s important for patients to follow their healthcare provider’s instructions and undergo regular monitoring to ensure the appropriate dosage is maintained. Always consult with a healthcare professional for personalized medical advice.
Hypertrophic cardiomyopathy
Mavacamten has a generally favorable safety profile.
No Interactions Reported
$10.00 – $100.00
$1,000-$1,500 per month

A Synopsis of

Mavacamten

Mavacamten is a novel drug that has shown promising results in the treatment of obstructive hypertrophic cardiomyopathy (HCM). This condition is characterized by the thickening of the heart muscle, which can lead to symptoms such as chest pain, shortness of breath, and fatigue. Mavacamten works by targeting the underlying cause of HCM, which is an overactive protein called myosin.

Clinical trials have demonstrated that mavacamten can effectively reduce the thickness of the heart muscle and improve symptoms in patients with HCM. In addition to its therapeutic benefits, mavacamten has also been shown to be well-tolerated with minimal side effects.

As a medical professional, it is important to consider mavacamten as a potential treatment option for patients with obstructive HCM who have not responded well to traditional therapies. It is important to discuss the potential benefits and risks of mavacamten with patients, as well as monitor their progress closely while on the medication.

Overall, mavacamten represents a promising advancement in the treatment of obstructive HCM and offers hope for patients who are struggling with this challenging condition. As more research is conducted and more data becomes available, mavacamten may become an important tool in our arsenal against HCM.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN